Saturday 17 October 2026
Export MD’s income statement to Excel — free account
Pediatrix Medical Group, Inc.
MD Healthcare Medical Care Facilities
Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024. In the quarter to June 2026, revenue grew 4.04%, EPS grew 6.52%, free cash flow fell 6.56% and total debt fell 3.84%, each against the same quarter a year earlier.
27.38
0.38
−1.37%
Follow MD
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 20.39% | 20.89% | 20.28% | 19.98% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
7 | 8 | 7 | 7 | |
| 8.26% | 8.57% | 7.52% | 7.59% | ||
ROIC |
12.69% | 11.97% | 13.55% | 12.09% | |
Return on Tangible Assets |
88.61% | 93.93% | 48.11% | 44.64% | |
Average Days of Receivables |
44.72 | 44.78 | 46.21 | 44.61 | |
Free Cash Flow per Share |
2.88 | 2.93 | 3.00 | 3.23 | |
Free Cash Flow |
228.61 | 237.32 | 252.63 | 273.39 | |
Capital Expenditures |
(18.25) | (21.39) | (18.46) | (16.61) | |
| Other line items | |||||
Cash ROIC |
12.23% | 13.20% | 12.87% | 13.97% | |
Accounts Receivable Turnover |
8.03 | 7.89 | 7.43 | 7.35 | |
Accounts Payable Turnover |
4.76 | 6.06 | 3.47 | 4.16 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
76.57 | 60.57 | 107.83 | 90.15 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.23) | (0.23) | (0.24) | (0.21) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.72% | 12.55% | 12.58% | 12.41% | |
Share Based Compensation of Revenue |
1.04% | 0.99% | 0.94% | 0.80% | |
Interest Coverage |
6.31 | 6.23 | 5.81 | 5.40 | |
Operating CF/Net income |
1.41 | 1.48 | 1.64 | 1.79 | |
Depreciation/Fixed assets |
0.61 | 0.57 | 0.58 | 0.62 | |
Capex/Depreciation |
(0.77) | (0.91) | (0.81) | (0.69) | |
Revenue per Share |
24.55 | 23.88 | 22.76 | 22.72 | |
Operating CF per Share |
3.11 | 3.20 | 3.22 | 3.43 | |
Capex per Share |
(0.23) | (0.26) | (0.22) | (0.20) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates